Heffter Research Institute
Heffter’s research informs the public about the beneficial applications of psychedelics for both science and public health. That research provides scientific knowledge that guides scientists toward new experiments to understand the brain and consciousness. Based on Heffter’s support for depression and anxiety in cancer patients, the Usona Institute has now begun their research to make psilocybin treatment available for anyone with depression. Current Heffter clinical trials will offer medical evidence to create new treatments for everyone with addictions and other conditions.